Affiliation:
1. Department of Bio and Healing Convergence, Graduate School, Konkuk University, Seoul 05029, Republic of Korea
2. Department of Systems Biotechnology, Konkuk University, Seoul 05029, Republic of Korea
Abstract
Anxiety disorders are the most prevalent and disabling mental disorders, causing health-related burdens. With the increasing demand for and interest in safe and acceptable anxiolytics, several studies report the anxiolytic effects of lavender aromatherapy, providing evidence of its physiological and psychological effects. However, existing reviews comprehensively cover the effects of different modes of delivering aromatherapy. Therefore, this review assesses the efficacy of lavender essential oil inhalation in reducing anxiety. The titles and abstracts of relevant articles published over the last five years were searched in PubMed, Web of Science, and Scopus databases. This review only included clinical trials that utilized lavender inhalation for anxiety treatment. Eleven studies comprising 972 participants were included. Of these, 10 reported significantly decreased anxiety levels after lavender oil inhalation. The physiological measures of vital signs, including blood pressure, heart rate, respiratory rate, pulse, and saturation, were conducted in three trials, showing that lavender oil inhalation could physiologically affect anxiety levels. Lavender oil inhalation is a safe and feasible anxiolytic intervention for treating people with diverse types of anxiety. Data from further studies with a high-quality design and accurate information are necessary to confirm the validity of these findings and elucidate the anxiety-reducing mechanisms of lavender inhalation.
Subject
Health Information Management,Health Informatics,Health Policy,Leadership and Management
Reference68 articles.
1. Global prevalence of anxiety disorders: A systematic review and meta-regression;Baxter;Psychol. Med.,2013
2. Epidemiology of anxiety disorders in the 21st century;Bandelow;Dial. Clin. Neurosci.,2022
3. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National comorbidity Survey Replication;Kessler;Arch. Gen. Psychiatry,2005
4. Epidemiology of anxiety disorders: From surveys to nosology and back;Stein;Dial. Clin. Neurosci.,2017
5. GBD 2019 Diseases and Injuries Collaborators (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1204–1222.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献